Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 2 3Phase EARLY_PHASE1 2Phase 3 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Colorectal Neoplasia 1

Interventions

Magnetic Resonance Spectroscopy 26pembrolizumab 17Radiotherapy 17Specimen Handling 16Nivolumab 15Cyclophosphamide 14Temozolomide 11Biopsy 11fludarabine 9Fluorodeoxyglucose F18 9X-Rays 8Etoposide 7Bevacizumab 7Standard of Care 6Radiation 6Paclitaxel 6Dexamethasone 6Cisplatin 6Carboplatin 6Surgical Procedures, Operative 5Ipilimumab 5Doxorubicin 5Aspirin 5venetoclax 4fluciclovine F-18 4atezolizumab 4abemaciclib 4Vincristine 4Rituximab 4Radiosurgery 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Omeprazole × 1 year × Clear all
NCT04930991 2026-06-01

OU202005AJ

University of Oklahoma

Phase EARLY_PHASE1 Terminated
25 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06378398 2026-03-13

A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Completed
21 enrolled
Gastrointestinal

Colorectal Neoplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡